150 related articles for article (PubMed ID: 12224345)
1. Reteplase for clearance of occluded venous catheters.
Owens L
Am J Health Syst Pharm; 2002 Sep; 59(17):1638-40. PubMed ID: 12224345
[No Abstract] [Full Text] [Related]
2. Using alteplase to clear occlusions.
Moureau N
Nursing; 2002 Jan; 32(1):73. PubMed ID: 12926500
[No Abstract] [Full Text] [Related]
3. Alteplase (Cathflo Activase).
Middleton G; Ruzevick B
Clin J Oncol Nurs; 2004 Aug; 8(4):417-8, 420. PubMed ID: 15354930
[No Abstract] [Full Text] [Related]
4. Does low-dose heparin maintain central venous access device patency?: a comparison of heparin versus saline during a period of heparin shortage.
Jonker MA; Osterby KR; Vermeulen LC; Kleppin SM; Kudsk KA
JPEN J Parenter Enteral Nutr; 2010; 34(4):444-9. PubMed ID: 20631392
[TBL] [Abstract][Full Text] [Related]
5. Interventions for restoring patency of occluded central venous catheter lumens (Review).
van Miert C; Hill R; Jones L
Evid Based Child Health; 2013 Mar; 8(2):695–749. PubMed ID: 24482900
[No Abstract] [Full Text] [Related]
6. Safety, dose, and timing of reteplase in treating occluded central venous catheters in children with cancer.
Terrill KR; Lemons RS; Goldsby RE
J Pediatr Hematol Oncol; 2003 Nov; 25(11):864-7. PubMed ID: 14608195
[TBL] [Abstract][Full Text] [Related]
7. Alteplase (TPA) for clotted dialysis catheters.
Hathiwala SC; Hristea I; Khalili V
Int J Artif Organs; 2000 Oct; 23(10):668-9. PubMed ID: 11075895
[No Abstract] [Full Text] [Related]
8. Lytic therapy in central venous catheters for hemodialysis.
McFarland HF; Dinwiddie L; Ferrell J; Forloines-Lynn S
Nephrol Nurs J; 2002 Aug; 29(4):355-60; quiz 361-2. PubMed ID: 12224368
[TBL] [Abstract][Full Text] [Related]
9. Alteplase licensed for catheter clearance.
Thompson CA
Am J Health Syst Pharm; 2001 Nov; 58(21):2011, 2014. PubMed ID: 11715818
[No Abstract] [Full Text] [Related]
10. Ultrasound-assisted drug delivery for treatment of venous thrombosis: a case study.
Marchiondo K; Frink A
Dimens Crit Care Nurs; 2008; 27(5):203-8. PubMed ID: 18724175
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of management of CVAD occlusions.
Peng C; Monagle P; Newall F
Arch Dis Child; 2011 Sep; 96(9):885-7. PubMed ID: 21398316
[TBL] [Abstract][Full Text] [Related]
12. Management of a large organized intraatrial catheter-tip thrombus in a child with acquired immunodeficiency syndrome using escalating tissue plasminogen activator infusions.
Mathur M; Desai N; Sharma J; Rao SP; Goldman GM
Pediatr Crit Care Med; 2005 Jan; 6(1):79-82. PubMed ID: 15636665
[TBL] [Abstract][Full Text] [Related]
13. Catheter-directed tissue plasminogen activator infusion and concurrent systemic anticoagulation with heparin to treat portal vein thrombosis post orthoptic liver transplantation.
Gill P; Oniscu GC; Mayer DA; Mirza DF; Olliff S
Transplantation; 2009 Aug; 88(4):595-6. PubMed ID: 19696645
[No Abstract] [Full Text] [Related]
14. Restoration of flow following haemodialysis catheter thrombus. Analysis of rt-PA infusion in tunnelled dialysis catheters.
Davies J; Casey J; Li C; Crowe AV; McClelland P
J Clin Pharm Ther; 2004 Dec; 29(6):517-20. PubMed ID: 15584939
[TBL] [Abstract][Full Text] [Related]
15. Catheter-directed therapy in deep vein thrombosis: May-Thurner syndrome.
Howley F; Motyer R; Torreggiani W; Govendar P
Br J Hosp Med (Lond); 2019 Oct; 80(10):610-611. PubMed ID: 31589519
[No Abstract] [Full Text] [Related]
16. Treatment of superior mesenteric and portal vein thrombosis with direct thrombolytic infusion via an operatively placed mesenteric catheter.
Kaplan JL; Weintraub SL; Hunt JP; Gonzalez A; Lopera J; Brazzini A
Am Surg; 2004 Jul; 70(7):600-4. PubMed ID: 15279182
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of recombinant tissue plasminogen activator for venous thrombosis after paediatric heart surgery.
Justice LB; Nelson DP; Palumbo J; Sawyer J; Patel MN; Byrnes JW
Cardiol Young; 2018 Feb; 28(2):214-221. PubMed ID: 28889818
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of local instillation of recombinant tissue plasminogen activator for restoring occluded central venous catheters in neonates.
Soylu H; Brandão LR; Lee KS
J Pediatr; 2010 Feb; 156(2):197-201.e1. PubMed ID: 19969306
[TBL] [Abstract][Full Text] [Related]
19. Analysis of rt-PA infusion in tunnelled dialysis catheters.
Davies J; Casey J; Li C; Crowe AV; McClelland P
EDTNA ERCA J; 2005; 31(2):75-8. PubMed ID: 16180551
[TBL] [Abstract][Full Text] [Related]
20. TROPICS 1: a phase III, randomized, double-blind, placebo-controlled study of tenecteplase for restoration of function in dysfunctional central venous catheters.
Gabrail N; Sandler E; Charu V; Anas N; Lim E; Blaney M; Ashby M; Gillespie BS; Begelman SM
J Vasc Interv Radiol; 2010 Dec; 21(12):1852-8. PubMed ID: 21111365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
